Evidence map›Paper›PMID 32967875›Full record

Observational studyBMJ open2020

Predicted quality benefits of achievable performance benchmarks of chronic heart failure care in China: results from a nationwide observational study.

Chang Yin, Xi Li, Chao Wang, Jingkun Li, Xiaoqiang Bao, Qiuju Zhang, Yupeng Wang, Xudong Ma, Meina Liu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chang Yin *Information Center, National Institute of Hospital Administration, Beijing, China.
Xi Li *Biostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Chao WangBiostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Jingkun LiBiostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Xiaoqiang BaoBiostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Qiuju ZhangBiostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Yupeng WangBiostatistics, Harbin Medical University, Harbin, Heilongjiang, China.
Xudong MaMedical Quality Evaluation Office, National Health Commission of the People's Republic of China, Beijing, China maxudong80@163.com liumeina369@163.com.ORCID 0000-0002-9924-0682
Meina LiuPublic Health College, Harbin Medical University, Harbin, China maxudong80@163.com liumeina369@163.com.
Harbin Medical University · CNNational Health and Family Planning Commission · CNNational Institute of Hospital Administration · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to set a data-driven achievable performance benchmark, explore the process-outcome association and speculate about the net gain in quality improvement with benchmarking.

designObservational study.

settingPatient survey conducted at 466 secondary and tertiary hospitals across 31 provinces, autonomous regions and municipalities in China.

participants183 334 patients diagnosed with chronic heart failure (CHF) who were treated at 466 Chinese hospitals from January 2011 through May 2017. PRIMARY INDEPENDENT VARIABLES: Hospital process composite performance (HPCP). SECONDARY INDEPENDENT VARIABLES: Patient-level and hospital-level characteristics. PRIMARY OUTCOME MEASURE: Patients getting better or recovered after treatment, in-hospital mortality, length of hospital stay (LOS) and medical cost.

methodsHPCP was calculated using denominator-based weights. Mixed random-intercept models were used to evaluate the contributions of HPCP on patient outcomes and to speculate quality improvement after adjusting HPCP to benchmark level.

resultsWhen all hospitals were to operate at the benchmark level, the proportion of patients getting better or recovered after treatment would increase in most hospitals, particularly those with low baseline rates. However, there was no evidence for lowering in-hospital mortality, significant savings in cost or shortening LOS.

conclusionsIncreasing the adherence rate of CHF care and closing the gap in HPCP between hospitals have important implications for improving patient condition.

Indexed as

BenchmarkingHeart FailureChinaHospital MortalityHospitalsHumanshealth & safetyheart failurequality in health care

Identifiers

PMID32967875
PMCPMC7513604
OpenAlexW3087772172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.